Modux
A co-pilot for chemistry discovery teams working across targets, compounds, safety, and patent evidence.
Modux coordinates public research integrations into a single evidence-led workflow: map target context, retrieve chemical starting points, compare assay provenance, flag safety signals, and pressure-test novelty or FTO.
Ranked evidence summary, tracked IDs, confidence limits, and exactly scoped next actions for a scientist to review.
One workspace for discovery evidence
Ground disease, pathway, gene, and protein context before ranking tractability.
Pull known ligands, activities, identifiers, synonyms, and physicochemical properties.
Resolve candidates and flag hazard, exposure, and bioactivity signals early.
Run initial novelty and Freedom-to-Operate screens with patent and USPTO evidence.
Built for source-aware iteration
Research work rarely moves in a straight line. Modux keeps the chain of evidence visible as a question becomes a target list, then a compound set, then a safety and IP triage package.
Start with a disease, target, pathway, scaffold, compound, or patent question.
Resolve identifiers before comparing evidence across sources.
Rank candidates by biological relevance, assay quality, properties, safety, and IP risk.
Leave every answer with the IDs, gaps, and next actions needed to continue.
For chemistry teams that need reviewable shortlists
Modux is in closed alpha with teams evaluating AI-assisted discovery workflows. Access is intended for scientists, founders, analysts, and IP stakeholders who need traceable research support.
- target-to-ligand evidence review
- candidate comparison across potency, properties, and safety
- early novelty or FTO triage for a scaffold or series